Revised classification/nomenclature of vitiligo and related issues: The Vitiligo Global Issues Consensus Conference

Pigment Cell and Melanoma Research

Volumn 25, Issue 3, 2012, Pages

  Ezzedine, K ^a,b   Lim, H W ^c   Suzuki, T ^d   Katayama, I ^e   Hamzavi, I ^c   Lan, C C E ^f   Goh, B K ^g   Anbar, T ^h   Silva de Castro, C ⁱ   Lee, A Y ^j   Parsad, D ^k   Van Geel, N ^l   Le Poole, I C ^m   Oiso, N ⁿ   Benzekri, L ^o   Spritz, R ^p   Gauthier, Y ^a,b   Hann, S K ^q   Picardo, M ^r   Taieb, A ^a,b  

^a HÔPITAL PELLEGRIN   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c HENRY FORD HOSPITAL   (United States)

^d YAMAGATA UNIVERSITY   (Japan)

^e OSAKA UNIVERSITY   (Japan)

^f KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^g NATIONAL SKIN CENTRE   (Singapore)

^h MINIA UNIVERSITY   (Egypt)

ⁱ FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^j Dongguk University Ilsan Hospital   (South Korea)

^k POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^l GHENT UNIVERSITY HOSPITAL   (Belgium)

^m Oncology Institute   (United States)

ⁿ KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^o IBN SINA HOSPITAL   (Morocco)

^p UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^q Drs Woo and Hann's Skin Center   (South Korea)

^r SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

more..

Author keywords

Consensus conference; Vitiligo

Indexed keywords

ACCURACY; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL RESEARCH; CONSENSUS; DISEASE CLASSIFICATION; HUMAN; ISOMORPHIC PHENOMENON; NOMENCLATURE; RELIABILITY; SKIN DISEASE; VITILIGO; CLASSIFICATION; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DISEASE COURSE; INTERNATIONAL COOPERATION; ORGANIZATION; ORGANIZATION AND MANAGEMENT;

AUTOIMMUNE DISEASES; CONGRESSES AS TOPIC; CONSENSUS; DISEASE PROGRESSION; HUMANS; INTERNATIONAL COOPERATION; TERMINOLOGY AS TOPIC; VITILIGO;

EID: 84865318593     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2012.00997.x     Document Type: Article

References (72)

1. Attili, V.R., and Attili, S.K. (2008). Lichenoid inflammation in vitiligo - a clinical and histopathologic review of 210 cases. Int. J. Dermatol. 47, 663-669.
2. Barona, M.I., Arrunátegui, A., Falabella, R., and Alzate, A. (1995). An epidemiologic case-control study in a population with vitiligo. J. Am. Acad. Dermatol. 33, 621-625.
3. Boissy, R.E. (2010). Occupational vitiligo. In Vitiligo, M. Picardo, and A. Taieb, eds. (Heidelberg: Springer Verlag), pp. 175-180.
4. Boissy, R.E., and Manga, P. (2004). On the etiology of contact/occupational vitiligo. Pigment Cell Res. 17, 208-214.
5. Boissy, R.E., and Nordlund, J.J. (1995). Biology in vitiligo. In Cutaneous Medicine and Surgery: An Integrated Program in Dermatology, K.A. Arndt, P.E. LeBoit, J.K. Robinson, and B.U. Wintroub, eds. (Philadelphia: W. B. Saunders Company), pp. 1210-1218.
6. Cario-André, M., Pain, C., Gauthier, Y., and Taïeb, A. (2007). The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis. Pigment Cell Res. 20, 385-393.
7. Cui, J., Arita, Y., and Bystryn, J.C. (1993). Cytolytic antibodies to melanocytes in vitiligo. J. Invest. Dermatol. 100, 812-815.
8. Cummings, M.P., and Nordlund, J.J. (1995). Chemical leukoderma: fact or fancy. Am. J. Contact Dermatitis 6, 122-127.
9. Dupré, A., and Christol, B. (1978). Cockade-like vitiligo and linear vitiligo a variant of fitzpatrick's trichrome vitiligo. Arch. Dermatol. Res. 262, 197-203.
10. El-Nasr, H.S., and El-Hefnawi, H. (1963). Koebner's phenomenon in dermatology. A study and report of some unusual stigmata of this phenomenon. J. Egypt Med. Assoc. 46, 1067-1086.
11. Ezzedine, K., Diallo, A., Léauté-Labréze, C. et al. (2011a). Multivariate analysis of factors associated with early-onset segmental and nonsegmental vitiligo: a prospective observational study of 213 patients. Br. J. Dermatol. 165, 44-49.
12. Ezzedine, K., Diallo, A., Léauté-Labréze, C. et al. (2011b). Halo nevi and leukotrichia are strong predictors of the passage to mixed vitiligo in a subgroup of segmental vitiligo. Br. J. Dermatol. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22032627 (accessed 26 December 2011)..
13. Ezzedine, K., Gauthier, Y., Léauté-Labréze, C., Marquez, S., Bouchtnei, S., Jouary, T., and Taieb, A. (2011c). Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): a retrospective case series of 19 patients. J. Am. Acad. Dermatol. 65, 965-971.
14. Falabella, R. (2005). Surgical approaches for stable vitiligo. Dermatol. Surg. 31, 1277-1284.
15. Falabella, R., Escobar, C.E., Carrascal, E., and Arroyave, J.A. (1988). Leukoderma punctata. J. Am. Acad. Dermatol. 18, 485-494.
16. Falabella, R., Arrunategui, A., Barona, M.I., and Alzate, A. (1995). The minigrafting test for vitiligo: detection of stable lesions for melanocyte transplantation. J. Am. Acad. Dermatol. 32, 228-232.
17. Gauthier, Y. (1995). The importance of Koebner's phenomenon in the induction of vitiligo vulgaris lesions. Eur. J. Dermatol. 5, 704-708.
18. Gauthier, Y., and Benzekri, L. (2010). The Koebner's phenomenon. In Vitiligo, M. Picardo, and A. Taieb, eds. (Heidelberg: Springer Verlag), pp. 167-173.
19. Gauthier, Y., Cario Andre, M., and Taïeb, A. (2003). A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res. 16, 322-332.
20. Gawkrodger, D.J., Ormerod, A.D., Shaw, L., Mauri-Sole, I., Whitton, M.E., Watts, M.J., Anstey, A.V., Ingham, J., and Young, K. (2008). Guideline for the diagnosis and management of vitiligo. Br. J. Dermatol. 159, 1051-1076.
21. van Geel, N.A.C., Mollet, I.G., De Schepper, S., Tjin, E.P.M., Vermaelen, K., Clark, R.A., Kupper, T.S., Luiten, R.M., and Lambert, J. (2010). First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi. Pigment Cell Melanoma Res. 23, 375-384.
22. van Geel, N., De Lille, S., Vandenhaute, S., Gauthier, Y., Mollet, I., Brochez, L., and Lambert, J. (2011a). Different phenotypes of segmental vitiligo based on a clinical observational study. J. Eur. Acad. Dermatol. Venereol. 25, 673-678.
23. van Geel, N., Speeckaert, R., Taieb, A. et al. (2011b). Koebner's phenomenon in vitiligo: European position paper. Pigment Cell Melanoma Res. 24, 564-573.
24. van Geel, N., Speeckaert, R., Mollet, I., De Schepper, S., De Wolf, J., Tjin, E.P.M., Luiten, R.M., Lambert, J., and Brochez, L. (2012). In vivo vitiligo induction and therapy model: double-blind, randomized clinical trial. Pigment Cell Melanoma Res. 25, 57-65.
25. Gopinathan, T. (1965). A study of the lesion of vitiligo. Arch. Dermatol. 91, 397-404.
26. Gregorio, J., Meller, S., Conrad, C., Di Nardo, A., Homey, B., Lauerma, A., Arai, N., Gallo, R.L., Digiovanni, J., and Gilliet, M. (2010). Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons. J. Exp. Med. 207, 2921-2930.
27. Hamzavi, I., Jain, H., McLean, D., Shapiro, J., Zeng, H., and Lui, H. (2004). Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index. Arch. Dermatol. 140, 677-683.
28. Hann, S.K., and Lee, H.J. (1996). Segmental vitiligo: clinical findings in 208 patients. J. Am. Acad. Dermatol. 35, 671-674.
29. Hann, S.K., and Nordlund, J.J. (2000). Clinical features of generalized vitiligo. In Vitiligo, S.K. Hann, and J.J. Nordlund, eds. (Oxford: Blackwell Publishing Ltd.), pp. 81-88.
30. Hann, S.K., Park, Y.K., Lee, K.G., Choi, E.H., and Im, S. (1992). Epidermal changes in active vitiligo. J. Dermatol. 19, 217-222.
31. Hann, S.K., Chun, W.H., and Park, Y.K. (1997a). Clinical characteristics of progressive vitiligo. Int. J. Dermatol. 36, 353-355.
32. Hann, S.K., Park, Y.K., and Chun, W.H. (1997b). Clinical features of vitiligo. Clin. Dermatol. 15, 891-897.
33. Hann, S.K., Chang, J.H., Lee, H.S., and Kim, S.M. (2000). The classification of segmental vitiligo on the face. Yonsei Med. J. 41, 209-212.
34. Happle, R. (2001). [Segmental type 2 manifestation of autosome dominant skin diseases. Development of a new formal genetic concept]. Hautarzt 52, 283-287.
35. Happle, R. (2007). Superimposed segmental manifestation of polygenic skin disorders. J. Am. Acad. Dermatol. 57, 690-699.
36. Kim, D.-Y., Oh, S.H., and Hann, S.-K. (2011). Classification of segmental vitiligo on the face: clues for prognosis. Br. J. Dermatol. 164, 1004-1009.
37. Koebner, H. (1876). Zur aetiologie der psoriasis. Vrtljscher Dermatol. Syphil. 8, 559-561.
38. Koga, M., and Tango, T. (1988). Clinical features and course of type A and type B vitiligo. Br. J. Dermatol. 118, 223-228.
39. Kostopoulou, P., Jouary, T., Quintard, B., Ezzedine, K., Marques, S., Boutchnei, S., and Taieb, A. (2009). Objective vs. subjective factors in the psychological impact of vitiligo: the experience from a French referral centre. Br. J. Dermatol. 161, 128-133.
40. Lahiri, K., Malakar, S., and Sarma, N. (2004a). Herpes-simplexinduced lip leucoderma revisited. Dermatology (Basel) 208, 182.
41. Lahiri, K., Malakar, S., Sarma, N., and Banerjee, U. (2004b). Inducing repigmentation by regrafting and phototherapy (311 nm) in punch grafting failure cases of lip vitiligo: a pilot study. Indian J. Dermatol. Venereol. Leprol. 70, 156-158.
42. Le Poole, I.C., and Das, P.K. (1997). Microscopic changes in vitiligo. Clin. Dermatol. 15, 863-873.
43. Le Poole, I.C., and Luiten, R.M. (2008). Autoimmune etiology of generalized vitiligo. Curr. Dir. Autoimmun. 10, 227-243.
44. Le Poole, I.C., Das, P.K., van den Wijngaard, R.M., Bos, J.D., and Westerhof, W. (1993). Review of the etiopathomechanism of vitiligo: a convergence theory. Exp. Dermatol. 2, 145-153.
45. Lerner, A.B. (1971). On the etiology of vitiligo and gray hair. Am. J. Med. 51, 141-147.
46. Malakar, S., Lahiri, K., and Malakar, R.S. (2000). How unstable is the concept of stability in surgical repigmentation of vitiligo? Dermatology (Basel) 201, 182-183.
47. Mashayekhi, V., Javidi, Z., Kiafar, B., Manteghi, A.A., Saadatian, V., Esmaeili, H.A., and Hosseinalizadeh, S. (2010). Quality of life in patients with vitiligo: a descriptive study on 83 patients attending a PUVA therapy unit in Imam Reza Hospital, Mashad. Indian J. Dermatol. Venereol. Leprol. 76, 592.
48. Miller, R.A. (1982). The Koebner phenomenon. Int. J. Dermatol. 21, 192-197.
49. Moellmann, G., Klein-Angerer, S., Scollay, D.A., Nordlund, J.J., and Lerner, A.B. (1982). Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo. J. Invest. Dermatol. 79, 321-330.
50. Mulekar, S.V., Al Issa, A., Asaad, M., Ghwish, B., and Al Eisa, A. (2006). Mixed vitiligo. J. Cutan. Med. Surg. 10, 104-107.
51. Njoo, M.D., Das, P.K., Bos, J.D., and Westerhof, W. (1999). Association of the Köbner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch. Dermatol. 135, 407-413.
52. Ormsby, O.S., and Montgomery, H. (1948). Koebner's Phenomenon in Dermatology: A Study and Report of Some Unusual Stigmata of this Phenomenon. (Philadelphia: Lea and Febriger), pp. 306.
53. Ortonne, J.P. (1983). Vitiligo. In Vitiligo and Other Hypomelanosis of Hair and Skin, J.P. Ortonne, D.B. Mosher, and T.B. Fitzpatrick, eds. (New-York: Plenum Medical Books), pp. 163-310.
54. Ortonne, J.P. (2000). Depigmentation of hair and mucous membrane. In Vitiligo, 1st edn, S.K. Hann, and J.J. Nordlund, eds. (Oxford: Blackwell Publishing Ltd.), pp. 76-80.
55. Parsad, D., and Gupta, S. (2008). Standard guidelines of care for vitiligo surgery. Indian J. Dermatol. Venereol. Leprol. 74(Suppl), S37-S45.
56. Passeron, T., and Ortonne, J.P. (2010). Generalized vitiligo. In Vitiligo, M. Picardo, and A. Taieb, eds. (Heidelberg: Springer Verlag), pp. 35-39.
57. Schallreuter, K.U., Lemke, R., Brandt, O., Schwartz, R., Westhofen, M., Montz, R., and Berger, J. (1994). Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients. Dermatology (Basel) 188, 269-275.
58. Schallreuter, K.U., Krüger, C., Rokos, H., Hasse, S., Zothner, C., and Panske, A. (2007). Basic research confirms coexistence of acquired Blaschkolinear Vitiligo and acrofacial Vitiligo. Arch. Dermatol. Res. 299, 225-230.
59. Schallreuter, K.U., Krüger, C., Würfel, B.A., Panske, A., and Wood, J.M. (2008). From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo. Int. J. Dermatol. 47, 743-753.
60. Sharquie, K.E., Mehenna, S.H., Naji, A.A., and Al-Azzawi, H. (2004). Inflammatory changes in vitiligo: stage I and II depigmentation. Am. J. Dermatopathol. 26, 108-112.
61. Spritz, R.A. (2012). Six decades of vitiligo genetics: genome-wide studies provide insights into autoimmune pathogenesis. J. Invest. Dermatol. 132, 268-273.
62. Sweet, R.D. (1978). Vitiligo as a Köbner phenomenon. Br. J. Dermatol. 99, 223-224.
63. Taieb, A., and Picardo, M. (2010). Epidemiology, definitions and classification. In Vitiligo, M. Picardo, and A. Taieb, eds. (Heidelberg: Springer Verlag), pp. 13-24.
64. Taïeb, A., and Picardo, M. (2007). The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res. 20, 27-35.
65. Taïeb, A., and Picardo, M. (2009). Clinical practice. Vitiligo. N. Engl. J. Med. 360, 160-169.
66. Taïeb, A., Morice-Picard, F., Jouary, T., Ezzedine, K., Cario-André, M., and Gauthier, Y. (2008). Segmental vitiligo as the possible expression of cutaneous somatic mosaicism: implications for common non-segmental vitiligo. Pigment Cell Melanoma Res. 21, 646-652.
67. Uda, H., Takei, M., and Mishima, Y. (1984). Immunopathology of vitiligo vulgaris, Sutton's leukoderma and melanoma-associated vitiligo in relation to steroid effects. II. The IgG and C3 deposits in the skin. J. Cutan. Pathol. 11, 114-124.
68. Wang, C.Q.F., Cruz-Inigo, A.E., Fuentes-Duculan, J., Moussai, D., Gulati, N., Sullivan-Whalen, M., Gilleaudeau, P., Cohen, J.A., and Krueger, J.G. (2011a). Th17 cells and activated dendritic cells are increased in vitiligo lesions. PLoS ONE 6, e18907.
69. Wang, K.-Y., Wang, K.-H., and Zhang, Z.-P. (2011b). Health-related quality of life and marital quality of vitiligo patients in China. J. Eur. Acad. Dermatol. Venereol. 25, 429-435.
70. Whitton, M.E., Pinart, M., Batchelor, J., Lushey, C., Leonardi-Bee, J., and González, U. (2010). Interventions for vitiligo. Cochrane Database Syst. Rev. CD003263.
71. van den Wijngaard, R., Wankowicz-Kalinska, A., Le Poole, C., Tigges, B., Westerhof, W., and Das, P. (2000). Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. Lab. Invest. 80, 1299-1309.
72. Yagi, H., Tokura, Y., Furukawa, Y., and Takigawa, M. (1997). Vitiligo with raised inflammatory borders: involvement of T cell immunity and keratinocytes expressing MHC class II and ICAM-1 molecules. Eur. J. Dermatol. 7, 19-22.6